Cystitis Glandularis Management
Diagnostic and Treatment Approach
- Antibiotics should be administered if there is evidence of concurrent bacterial infection, as recommended by the European Association of Urology 1
- Regular cystoscopic surveillance is recommended at 3-6 month intervals for the first 2 years, according to the National Comprehensive Cancer Network 2
- Urinary cytology should be performed periodically to monitor for potential malignant transformation, as suggested by the National Comprehensive Cancer Network 2
- Upper tract imaging should be considered every 1-2 years for high-risk cases, as recommended by the National Comprehensive Cancer Network 2
- For cystitis symptoms, first-line options include nitrofurantoin (100 mg twice daily for 5 days) if renal function is adequate, as recommended by the American Urological Association 3
- Anticholinergic medications can help manage irritative bladder symptoms, according to the European Association of Urology 1
- Non-steroidal anti-inflammatory drugs (NSAIDs) can be used for pain and inflammation, as recommended by the European Association of Urology 1
- Fluoroquinolones may be considered as second-line agents for persistent symptoms, as suggested by the European Association of Urology 1
- Inadequate follow-up can risk missed progression or recurrence, highlighting the importance of regular monitoring, as recommended by the National Comprehensive Cancer Network 2
- Overuse of antibiotics when no bacterial infection is present should be avoided, as cautioned by the European Association of Urology 1